Search for: "Merck and Co "
Results 761 - 780
of 1,266
Sort by Relevance
|
Sort by Date
6 Jan 2010, 6:00 am
Merck, 192 N.J. 372 (2007) (our prior post here), and then again to await Levine v. [read post]
5 Jan 2010, 11:44 pm
The noxiousness of the faux first-to-invent regime that the U.S. alone clings to is seldom exposed to the harsh daylight of the appeals court. [read post]
31 Dec 2009, 4:43 pm
------- Title: Merck & Co., Inc. v. [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
26 Dec 2009, 11:28 pm
Food and Drug Administration said it's "unlikely" Merck & Co.'s cholesterol drugs Vytorin and Zetia increase the risk of cancer or cancer-related death. [read post]
16 Dec 2009, 2:51 pm
The Federal Trade Commission announced in October 2009 that it will allow Schering-Plough Corporation's proposed $41.1 billion acquisition of Merck & Co., Inc. to proceed, subject to a consent order requiring the parties to each divest certain interests and assets in businesses where the FTC was concerned the transaction would have substantially reduced competition. [read post]
16 Dec 2009, 7:51 am
Co. v. [read post]
16 Dec 2009, 3:52 am
Merck also established that doctors rely on different sources of information, with some even rejecting out of hand research the company provides. [read post]
15 Dec 2009, 11:32 pm
Merck & Co. agreed to pay $4.85 billion to resolve more than 48,000 claims over the withdrawn painkiller. [read post]
14 Dec 2009, 12:28 pm
At least 900 lawsuits have been filed against pharmaceutical giant Merck & Co. [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) Rozerem (Ramelteon) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Takeda Pharmaceutical Co. [read post]
7 Dec 2009, 3:00 am
B-Roc Reps., Inc (Chicago IP Litigation Blog) Rothschild, Prof Gertrude Neumark - More settlements in and out of court for litigious LED professor (Green Patent Blog) SP Techs - N D Illinois: Inventor not allowed to intervene in patent dispute: SP Techs v Garmin Int’l (Chicago Intellectual Property Law Blog) US Copyright – Lawsuits and strategic steps Warner Music – Warner Music and Sony drop XM radio suit (IPKat) US Trademarks Joe Dreitler expounds on ‘The… [read post]
4 Dec 2009, 2:22 am
The Supreme Court considers the ‘inquiry notice’ standard in federal securities fraud cases Simpson Thacher & Bartlett LLP "The Supreme Court heard oral arguments yesterday in Merck & Co, Inc. v. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
3 Dec 2009, 6:21 am
Below, Akin Gump's John Wittenzellner recaps Monday's oral argument in Merck & Co., Inc. v. [read post]
2 Dec 2009, 7:50 am
The WSJ Law Blog discusses the “interesting†argument made by Merck during oral argument on Monday in Merck & Co., Inc. v. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango) General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill on trade… [read post]
1 Dec 2009, 6:46 am
Reynolds, noting that the justices seemed "reluctant to to give the pharmaceutical company Merck & Co. a "statute of limitations" way out of defending against a securities fraud class action. [read post]
30 Nov 2009, 9:17 pm
The Supreme Court heard argument today in the securities class action case, Merck & Co., Inc. v. [read post]
30 Nov 2009, 2:37 pm
United States and here for Merck & Co., Inc. v. [read post]
